Endocrinology Teams Top Recommendation We are a team of endocrinology experts, most of whom have personally experienced obesity and its related complications
showed that liraglutide 3.0 mg/day significantly decreased body weight, BMI, WC and Waist to Hip ratio (W/H) compared with the placebo group [62]
Science 168: 255257
The NDA is based on results from REDEFINE 1, a 68-week, phase 3, randomised, double-blind, placebo-and active-controlled trial that evaluated the efficacy and safety of once-weekly, CagriSema compared to semaglutide 2.4 mg alone, cagrilintide 2.4 mg alone, or placebo, all as an adjunct to lifestyle intervention in 3,417 adults with obesity (BMI 30 kg/m2) or overweight (BMI 27 kg/m2) with one or more obesity-related complications and without diabetes, and REDEFINE 2, a double-blind, randomised, placebo-controlled, 68-week, phase 3 trial that evaluated the efficacy and safety of once-weekly CagriSema versus placebo, as an adjunct to lifestyle intervention in 1,206 adults with type 2 diabetes and either obesity (BMI 30 kg/m2) or overweight (BMI 27 kg/m2)
Stomach acid and enzymes tend to break it apart before much can pass into the bloodstream
But not sure how to take it, and what is the best time to take it